Exosomes from IBS patients (IBS-exo) or controls (control-exo) are shown in Fig. 1A. Immunoblotting further confirmed the expression of markers CD9 and CD81 (Fig. 1B). The gene discussed is CD9; the disease is irritable bowel syndrome.